Get the Stockscreener App
25.96
4.21%
-1.14
Avidity Biosciences Inc Stock (RNA) Forecast
The Avidity Biosciences Inc (RNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $23.34, representing a -10.11% decrease from the current price of $25.96. The highest analyst price target is $26.31, and the lowest is $20.37.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RNA Price Target
Average 25.63
(-1.29% Downside)
Is Avidity Biosciences Inc (RNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.92 | Neutral |
| STOCH(9,6) | 69.41 | Neutral |
| STOCHRSI(14) | 40.98 | Neutral |
| MACD(12,26) | 0.7728 | Buy |
| ADX(14) | 17.75 | Neutral |
| William %R | -36.96 | Neutral |
| CCI(14) | 73.41 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
25.75
Buy
|
25.79
Buy
|
| MA20 |
24.86
Buy
|
25.24
Buy
|
| MA50 |
24.10
Buy
|
23.02
Buy
|
| MA100 |
17.89
Buy
|
19.36
Buy
|
| MA200 |
12.46
Buy
|
16.58
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, RNA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on RNA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.92 indicates that RNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 69.41 indicates that RNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.98 indicates that RNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.75 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 73.41 indicates that RNA is still overbought but not to an extreme extent.
Long-term RNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Avidity Biosciences Inc financial reports and earnings history, Avidity Biosciences Inc (RNA) stock could reach $18.99 by 2030, $11.76 by 2040 and $6.0876 by 2050. See the projected annual prices until 2050 of the Avidity Biosciences Inc stock below:
- Avidity Biosciences Inc (RNA) is expected to reach an average price of $7.1556 in 2035, with a high prediction of $9.9122 and a low estimate of $5.6023. This indicates an $-72.44% rise from the last recorded price of $25.96.
- Avidity Biosciences Inc (RNA) stock is projected to chart a bullish course in 2040, with an average price target of $11.71, representing an $-54.88% surge from its current level. The forecast ranges from a conservative $5.0182 to a sky-high $11.76.
- Our analysts predict Avidity Biosciences Inc (RNA) to jump -61.10% by 2045, soaring from $8.8526 to an average price of $10.10, potentially reaching $13.02. While $8.8526 is the low estimate, the potential upside is significant.
- Avidity Biosciences Inc (RNA) stock is expected to climb by 2050, reaching an average of $6.7176, a $-74.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.0876 and $5.7675, respectively, highlighting the market's uncertainty.
Avidity Biosciences Inc Stock (RNA) Year by Year Forecast
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2024
Our forecast for RNA stock price in 2024 now indicates an average price target of $21.82 with a high forecast of $34.78 and a low forecast of $8.86. The average prediction reflects an decrease of -15.95% from the last recorded price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $21.04 | $20.37 | $26.31 | -18.96% |
| July, 2024 | $25.83 | $20.71 | $29.84 | -0.49% |
| August, 2024 | $31.63 | $25.38 | $34.78 | +21.83% |
| September, 2024 | $24.99 | $23.57 | $33.36 | -3.73% |
| October, 2024 | $26.72 | $21.13 | $28.32 | +2.94% |
| November, 2024 | $29.67 | $25.13 | $30.04 | +14.30% |
| December, 2024 | $22.77 | $22.35 | $33.35 | -12.30% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2025
Avidity Biosciences Inc Stock (RNA) is expected to reach an average price of $20.95 in 2025, with a high prediction of $26.96 and a low estimate of $14.95. This indicates an -19.28% fall from the last recorded price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $19.78 | $19.22 | $25.98 | -23.80% |
| February, 2025 | $20.31 | $18.69 | $25.02 | -21.78% |
| March, 2025 | $19.16 | $17.17 | $25.49 | -26.19% |
| April, 2025 | $20.80 | $16.47 | $23.25 | -19.89% |
| May, 2025 | $21.10 | $16.86 | $23.06 | -18.72% |
| June, 2025 | $26.63 | $18.85 | $26.73 | +2.56% |
| July, 2025 | $19.36 | $18.51 | $26.96 | -25.42% |
| August, 2025 | $17.53 | $14.95 | $19.43 | -32.49% |
| September, 2025 | $19.94 | $15.48 | $21.93 | -23.19% |
| October, 2025 | $20.38 | $19.18 | $22.36 | -21.51% |
| November, 2025 | $23.49 | $17.67 | $24.26 | -9.52% |
| December, 2025 | $20.60 | $18.03 | $26.64 | -20.67% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2026
The predicted value for Avidity Biosciences Inc (RNA) in 2026 is set at an average of $16.36. Estimates vary from a peak of $24.40 to a trough of $8.3207, indicating an -36.99% surge from the present price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $21.17 | $19.36 | $24.40 | -18.45% |
| February, 2026 | $12.64 | $10.79 | $21.80 | -51.29% |
| March, 2026 | $12.34 | $12.23 | $15.10 | -52.47% |
| April, 2026 | $15.89 | $12.07 | $16.44 | -38.77% |
| May, 2026 | $17.16 | $14.11 | $18.75 | -33.90% |
| June, 2026 | $11.00 | $10.77 | $17.04 | -57.62% |
| July, 2026 | $10.54 | $8.444 | $12.55 | -59.41% |
| August, 2026 | $11.96 | $8.3207 | $13.22 | -53.92% |
| September, 2026 | $13.73 | $11.93 | $16.79 | -47.12% |
| October, 2026 | $19.38 | $12.70 | $21.01 | -25.34% |
| November, 2026 | $18.28 | $15.90 | $20.74 | -29.59% |
| December, 2026 | $11.68 | $11.07 | $18.84 | -55.00% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Avidity Biosciences Inc (RNA) is $14.13, with a high forecast of $23.21 and a low forecast of $5.0393. This indicates an -45.58% decrease from the last price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.30 | $10.47 | $14.31 | -52.63% |
| February, 2027 | $9.0917 | $8.3517 | $12.93 | -64.98% |
| March, 2027 | $17.30 | $7.2928 | $20.76 | -33.37% |
| April, 2027 | $21.17 | $15.32 | $21.59 | -18.45% |
| May, 2027 | $20.25 | $19.65 | $23.21 | -22.01% |
| June, 2027 | $17.51 | $16.86 | $22.86 | -32.54% |
| July, 2027 | $13.81 | $10.62 | $18.28 | -46.82% |
| August, 2027 | $8.3105 | $7.8705 | $15.04 | -67.99% |
| September, 2027 | $9.616 | $7.8627 | $10.21 | -62.96% |
| October, 2027 | $8.3304 | $8.1393 | $9.6171 | -67.91% |
| November, 2027 | $6.7849 | $6.3626 | $8.5815 | -73.86% |
| December, 2027 | $5.4704 | $5.0393 | $7.3438 | -78.93% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2028
In 2028, Avidity Biosciences Inc (RNA) is projected to reach an average price of $15.97, with a high projection of $29.60 and a low estimate of $2.3454. This indicates an -38.46% fall from the last price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.8948 | $3.6248 | $5.4915 | -85.00% |
| February, 2028 | $2.3892 | $2.3592 | $4.4261 | -90.80% |
| March, 2028 | $3.7848 | $2.3454 | $4.2037 | -85.42% |
| April, 2028 | $6.1792 | $3.4959 | $6.2192 | -76.20% |
| May, 2028 | $7.6948 | $5.9003 | $9.4236 | -70.36% |
| June, 2028 | $10.89 | $7.4659 | $11.05 | -58.05% |
| July, 2028 | $17.65 | $10.55 | $17.89 | -32.00% |
| August, 2028 | $22.18 | $13.84 | $25.21 | -14.56% |
| September, 2028 | $21.68 | $19.79 | $23.57 | -16.47% |
| October, 2028 | $21.22 | $20.10 | $29.60 | -18.24% |
| November, 2028 | $18.35 | $17.68 | $23.61 | -29.33% |
| December, 2028 | $25.07 | $18.02 | $27.15 | -3.41% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2029
The 2029 price forecast for Avidity Biosciences Inc Stock (RNA) is $22.96 on average, with a high prediction of $32.10 and a low estimate of $13.83. This represents an -11.55% decrease from the previous price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $28.95 | $22.51 | $32.10 | +11.50% |
| February, 2029 | $22.31 | $20.89 | $30.68 | -14.04% |
| March, 2029 | $22.63 | $18.45 | $25.25 | -12.82% |
| April, 2029 | $24.51 | $22.46 | $27.10 | -5.58% |
| May, 2029 | $20.10 | $19.68 | $30.69 | -22.56% |
| June, 2029 | $17.56 | $17.01 | $23.32 | -32.35% |
| July, 2029 | $18.82 | $16.39 | $22.37 | -27.50% |
| August, 2029 | $16.51 | $14.52 | $22.84 | -36.39% |
| September, 2029 | $17.19 | $13.83 | $20.49 | -33.78% |
| October, 2029 | $18.46 | $14.22 | $20.60 | -28.88% |
| November, 2029 | $23.99 | $16.21 | $24.09 | -7.59% |
| December, 2029 | $17.49 | $15.88 | $24.32 | -32.63% |
Avidity Biosciences Inc Stock (RNA) Price Forecast for 2030
Avidity Biosciences Inc Stock (RNA) is expected to reach an average price of $14.95 in 2030, with a high forecast of $24.03 and a low forecast of $5.868. This signifies an -42.41% decrease from the last price of $25.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.90 | $12.33 | $18.99 | -42.60% |
| February, 2030 | $17.32 | $12.86 | $19.31 | -33.28% |
| March, 2030 | $18.03 | $16.56 | $19.74 | -30.55% |
| April, 2030 | $17.25 | $15.05 | $19.21 | -33.56% |
| May, 2030 | $17.12 | $15.68 | $24.03 | -34.06% |
| June, 2030 | $20.41 | $15.42 | $21.79 | -21.39% |
| July, 2030 | $10.05 | $8.1982 | $20.73 | -61.29% |
| August, 2030 | $9.747 | $9.637 | $12.50 | -62.45% |
| September, 2030 | $12.36 | $9.4792 | $13.29 | -52.40% |
| October, 2030 | $14.58 | $10.37 | $16.17 | -43.85% |
| November, 2030 | $8.4258 | $8.1958 | $14.46 | -67.54% |
| December, 2030 | $8.7847 | $5.868 | $9.9703 | -66.16% |
0.84%
0.10%
Cap:
|
Volume (24h):